Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Drug Targets|June 2, 2015
SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?Annette Ahner, Raymond A Frizzell
American Journal of Physiology. Cell Physiology|November 20, 2015
Divergent signaling via SUMO modification: potential for CFTR modulationAnnette Ahner, Xiaoyan Gong, Raymond A Frizzell
Molecular Biology of the Cell|December 22, 2006
Small heat-shock proteins select deltaF508-CFTR for endoplasmic reticulum-associated degradationAnnette Ahner, Kunio Nakatsukasa, Hui Zhang, et al.
The Journal of Biological Chemistry|December 3, 2015
Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for DegradationXiaoyan Gong, Annette Ahner, Ariel Roldan, et al.
Molecular Biology of the Cell|November 8, 2018
Different SUMO paralogues determine the fate of wild-type and mutant CFTRs: biogenesis versus degradationXiaoyan Gong, Yong Liao, Annette Ahner, et al.
Trends in Cell Biology|September 8, 2004
Checkpoints in ER-associated degradation: excuse me, which way to the proteasome?Annette Ahner, Jeffrey L Brodsky
Cell|September 26, 2015
A combination therapy for cystic fibrosisJeffrey L Brodsky, Raymond A Frizzell
Cold Spring Harbor Perspectives in Medicine|June 8, 2012
Physiology of epithelial chloride and fluid secretionRaymond A Frizzell, John W Hanrahan
Pageof 6